Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 14, 2025

Multidimensional analysis of the role of BRI3BP in the occurrence, development and prognosis of esophageal cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

ZWZhulin WangZXZitong XiongTZTao Zeng

Discussion

Loading...

Member takes

Overview

Multidimensional analysis reveals BRI3BP as a notable biomarker for esophageal cancer, suggesting implications for immunotherapeutic response.

Key Points

  • BRI3BP expression is significantly higher in tumor samples compared to normal tissues from esophageal cancer patients.
  • This gene serves as a predictor of immunotherapeutic response, indicating its relevance in treatment planning.
  • The study explores BRI3BP's effects on m6A modification and regulation of cuproptosis in the context of esophageal cancer.
  • Identifying BRI3BP's role in the ceRNA regulatory network contributes to understanding the mechanisms driving esophageal cancer progression.

Cite This Study

Wang et al. (2025) studied this question.

synapsesocial.com/papers/689a02b6e6551bb0af8cc215https://doi.org/10.21203/rs.3.rs-6664868/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification and validation of RNA-binding protein-associated biomarkers in esophageal cancer2026
  2. 2Construction and validation of a prognostic model for esophageal cancer based on prognostic-related RNA-binding protein2024 · 1 citations
  3. 3[Auxiliary diagnosis and prognosis evaluation of KIF4A, RAD51AP1 and CDKN3 in esophageal cancer].2024 · 1 citations
  4. 4IGFBP1: A Key Regulatory Gene in the Oncogenesis and Progression of Esophageal Cancer2026
  5. 5Identification and validation of UBE2B as a prognostic biomarker promoting the development of esophageal carcinomas2024 · 1 citations